| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2009 | US20090203641 Antibiotic compositions and related screening methods |
| 08/13/2009 | US20090203640 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 08/13/2009 | US20090203639 Methylation Markers for Diagnoses and Treatment of Cancers |
| 08/13/2009 | US20090203638 Pharmaceutical compositions and methods for metabolic modulation |
| 08/13/2009 | US20090203637 Novel cytostatic 7-deazapurine nucleosides |
| 08/13/2009 | US20090203636 Prevention and Treatment of Cancer and Other Diseases |
| 08/13/2009 | US20090203635 HXAAA01 Polynucleotides |
| 08/13/2009 | US20090203634 Compositions and Uses of Amooranin Compounds |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090203632 Compositions and methods for treating contracture |
| 08/13/2009 | US20090203630 Process for preparing atazanavir bisulfate and novel forms |
| 08/13/2009 | US20090203628 Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition |
| 08/13/2009 | US20090203626 Pediatric Amino Acid Solution for Parenteral Nutrition |
| 08/13/2009 | US20090203621 Tripeptides that Down Regulate the Activity of Plasma Membrane transporters Including Sodium-D-Glucose Cotransporter Sglt1 |
| 08/13/2009 | US20090203609 Use of IL-1 inhibitors for treating IL-1 mediated diseases |
| 08/13/2009 | US20090203607 Method And Compositions For Simultaneously Regulating Memory And Mood |
| 08/13/2009 | US20090203605 Methods For Treating A Condition Characterized By Dysfunction In Protein Homeostasis |
| 08/13/2009 | US20090203596 Phosphatase Inhibitor Protein-1 As A Regulator of Cardiac Function |
| 08/13/2009 | US20090203595 Neuregulin variants and methods of screening and using thereof |
| 08/13/2009 | US20090203593 Immunogenic Constructs |
| 08/13/2009 | US20090203591 Methods and compositions for emergency contraception using endothelin receptor antagonists |
| 08/13/2009 | US20090203588 Outcome prediction and risk classification in childhood leukemia |
| 08/13/2009 | US20090203587 Diagnosis and Therapy of Cell Proliferative Disorders Characterized by Resistance to Trail Induced Apoptosis |
| 08/13/2009 | US20090203578 Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use |
| 08/13/2009 | US20090203577 Azepinoindole Derivatives As Pharmaceutical Agents |
| 08/13/2009 | US20090203573 Use of dietary fibres against muscle wasting |
| 08/13/2009 | US20090203572 Method for in Vitro Molecular Evolution of Protein Function |
| 08/13/2009 | US20090203144 Hiv-gag codon-optimised dna vaccines |
| 08/13/2009 | US20090203143 Trans-splicing mediated photodynamic therapy |
| 08/13/2009 | US20090203138 Small Interfering RNAs Targeting Feline Herpes Virus |
| 08/13/2009 | US20090203137 Compounds for the modulation of beta-catenin expression |
| 08/13/2009 | US20090203135 Glycoconjugates of RNA Interference Agents |
| 08/13/2009 | US20090203131 Polyamides for nucleic acid delivery |
| 08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/13/2009 | US20090203121 Nucleic acid agents for downregulating h19, and methods of using same |
| 08/13/2009 | US20090203072 Detection for HPV-Induced invasive cancers and their precursor lesions with invasive potential |
| 08/13/2009 | US20090203051 Targets in breast cancer for prognosis or therapy |
| 08/13/2009 | US20090203050 Molecular signaling pathways triggered by rituximab: prognostic, diagnostic, and therapeutic uses |
| 08/13/2009 | US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/13/2009 | US20090203028 Novel aptamers that bind to listeria surface proteins |
| 08/13/2009 | US20090203024 Secreted protein called 36p6d5 characteristic of tumors |
| 08/13/2009 | US20090202998 Method for the extraction of biomolecules from fixed tissues |
| 08/13/2009 | US20090202668 Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae |
| 08/13/2009 | US20090202667 Grape seeds extracts obtainable by fractioning on a resin |
| 08/13/2009 | US20090202662 Treatment of erectile dysfunction and libido enhancement |
| 08/13/2009 | US20090202660 Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation |
| 08/13/2009 | US20090202659 Modulation of Peripheral Clocks in Adipose Tissue |
| 08/13/2009 | US20090202649 Fenofibrate formulations |
| 08/13/2009 | US20090202647 Solid form of racemic rotigotine |
| 08/13/2009 | US20090202645 Intrasynovial formulations of stanozolol |
| 08/13/2009 | US20090202643 Oil-in-water emulsions containing lignan-class compounds and compositions containing the same |
| 08/13/2009 | US20090202642 Drug Delivery System Comprising Microparticles and Gelation System |
| 08/13/2009 | US20090202638 Bmp gene and fusion protein |
| 08/13/2009 | US20090202636 Pharmaceutical Composition |
| 08/13/2009 | US20090202634 Pharmaceutical dosage form |
| 08/13/2009 | US20090202633 Extended release formulations of guaifenesin |
| 08/13/2009 | US20090202632 Sublingual Buccal Effervescent |
| 08/13/2009 | US20090202631 Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| 08/13/2009 | US20090202630 Orally disintegrating tablet compositions of ranitidine and methods of manufacture |
| 08/13/2009 | US20090202629 Controlled release hydrocodone formulations |
| 08/13/2009 | US20090202628 Nanoparticles for protein drug delivery |
| 08/13/2009 | US20090202626 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | US20090202624 Method for detecting carcinoma and agent for suppressing carcinoma |
| 08/13/2009 | US20090202623 Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent |
| 08/13/2009 | US20090202615 Compositions for Treating Biofilms and Methods for Using Same |
| 08/13/2009 | US20090202612 Monolithic Intravaginal Rings Comprising Progesterone and Methods of Making and Uses Thereof |
| 08/13/2009 | US20090202611 Composite self-cohered web materials |
| 08/13/2009 | US20090202607 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 08/13/2009 | US20090202606 Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor |
| 08/13/2009 | US20090202604 Benzodiazepine Formulation in a Polyorthoester Carrier |
| 08/13/2009 | US20090202601 Method for inhibiting onset of or treating pollen allergy |
| 08/13/2009 | US20090202597 Ache-Nmda Combination Wafer |
| 08/13/2009 | US20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202582 Water-Disposable or Water-Soluble Polymer Film as a Vehicle for Dermatologic and Cosmetic Active Agents |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202572 Compositions and methods for modulating bone mass |
| 08/13/2009 | US20090202571 Bioreductively-activated prodrugs |
| 08/13/2009 | US20090202569 Prophylactic/Therapeutic Agent for Cancer |
| 08/13/2009 | US20090202567 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm |
| 08/13/2009 | US20090202566 Use of the ENDO-180 gene and polypeptide for diagnosis and treatment |
| 08/13/2009 | US20090202565 Torc polynucleotides and polypeptides and method of use |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202551 Immunomodulation by altering sphingosine 1-phosphate lyase (spl) activity |
| 08/13/2009 | US20090202545 Melanoma biomarker and methods of uses |
| 08/13/2009 | US20090202544 Methods of Treating Diseases by Targeting Silt3 |
| 08/13/2009 | US20090202543 Gene and polypeptide relating to breast cancer |
| 08/13/2009 | US20090202541 Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl)-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 08/13/2009 | US20090202540 Substituted oxazaphosphorines |
| 08/13/2009 | US20090202530 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 08/13/2009 | US20090202529 Use of egfr inhibitors to prevent or treat obesity |
| 08/13/2009 | US20090202528 Surface-Located Streptococcus Pneumoniae Polypeptides |
| 08/13/2009 | US20090202525 Dihydroisoindolones as allosteric modulators of glucokinase |
| 08/13/2009 | US20090202524 Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
| 08/13/2009 | US20090202520 Treatment and diagnostic methods for fibrosis related disorders |
| 08/13/2009 | US20090202519 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
| 08/13/2009 | US20090202518 Treatment of sepsis and inflammation with alpha2A Adrenergic antagonists |
| 08/13/2009 | US20090202516 Inhibition and treatment of gastrointestinal biofilms |
| 08/13/2009 | US20090202512 Proteins for use in human and animal staphylococcus infections |